Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. China NT Pharma Group Company Limited
  6. Summary
    1011   KYG2114L1059

CHINA NT PHARMA GROUP COMPANY LIMITED

(1011)
  Report
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
06/17/2021 06/18/2021 06/21/2021 06/22/2021 06/23/2021 Date
0.123 0.121 0.121 0.123 0.12 Last
58000 124000 126500 162500 413000 Volume
+2.50% -1.63% 0.00% +1.65% -2.44% Change
Estimated financial data (e)
Sales 2019 153 M 23,7 M 23,7 M
Net income 2019 -588 M -90,7 M -90,7 M
Net Debt 2019 955 M 147 M 147 M
P/E ratio 2019 -0,50x
Yield 2019 -
Sales 2020 222 M 34,2 M 34,2 M
Net income 2020 -358 M -55,2 M -55,2 M
Net Debt 2020 844 M 130 M 130 M
P/E ratio 2020 -0,63x
Yield 2020 -
Capitalization 191 M 29,4 M 29,4 M
EV / Sales 2019 8,05x
EV / Sales 2020 4,67x
Nbr of Employees 224
Free-Float 51,0%
More Financials
Company
CHINA NT PHARMA GROUP COMPANY LIMITED is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company mainly conducts its businesses through two segments. The Proprietary Product Production and Sales segment is engaged in the production and sales of NT branded products and generic drugs through its subsidiaries. The Miacalcic segment is engaged in... 
Sector
Pharmaceuticals
Calendar
08/24Earnings Release
More about the company
All news about CHINA NT PHARMA GROUP COMPANY LIMITED
04/30CHINA NT PHARMA  : Proposed granting of general mandates to issue shares and rep..
PU
04/06CHINA NT PHARMA  : Logs Lower Loss in 2020 as Revenue Soars 44%
MT
01/13CHINA NT PHARMA  : Board Urges Shareholders to Approve $10 Million Sale of Indus..
MT
2020CHINA NT PHARMA  : Voluntary announcement selection results of national centrali..
PU
2020CHINA NT PHARMA  : Supplemental announcement to the annual report for the year e..
PU
2020CHINA NT PHARMA  : Profit warning supplemental announcement
PU
2020CHINA NT PHARMA  : Voluntary announcement shusi approved in consistency evaluati..
PU
2019CHINA NT PHARMA  : Appointment and resignation of independent non-executive dire..
PU
2019CHINA NT PHARMA  : Resignation of executive and non-executive directors and chan..
PU
2019CHINA NT PHARMA  : Monthly progress update in relation to (1) major and connecte..
PU
2019CHINA NT PHARMA  : Extension of conditions precedent long stop date and further ..
PU
2019CHINA NT PHARMA  : Further delay in despatch of circular in relation to (1) majo..
PU
2017CHINA NT PHARMA  : Voluntary Announcement - Increase in Shareholding in the Comp..
PU
2017CHINA NT PHARMA  : Proposed granting of general mandates to issue shares and to ..
PU
2017CHINA NT PHARMA  : Change of Name of Principal Share Registrar and Transfer Offi..
PU
More news
News in other languages on CHINA NT PHARMA GROUP COMPANY LIMITED

- No features available -

More news
Chart CHINA NT PHARMA GROUP COMPANY LIMITED
Duration : Period :
China NT Pharma Group Company Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHINA NT PHARMA GROUP COMPANY LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Managers and Directors
NameTitle
Tit Ng Chairman & Chief Executive Officer
Jing Fang Chief Financial Officer
Bao Ming Ge General Manager-Research & Development
Tze Shan Yu Independent Non-Executive Director
Yu Biao Zhao Independent Non-Executive Director